北京大学医学部机构知识库
Advanced  
IR@PKUHSC  > 北京大学医药卫生分析中心  > 期刊论文
学科主题: 公共卫生
题名:
Evaluation of In-111-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability
作者: Shi, Jiyun1,2; Zhou, Yang1; Chakraborty, Sudipta1; Kim, Young-Seung1; Jia, Bing2; Wang, Fan2; Liu, Shuang1
关键词: integrin alpha(v)beta(3) ; In-111-labeled cyclic RGD peptides ; tumor imaging
刊名: THERANOSTICS
发表日期: 2011
DOI: 10.7150/thno/v01p0322
卷: 1, 页:322-340
收录类别: SCI
文章类型: Article
WOS标题词: Science & Technology
类目[WOS]: Medicine, Research & Experimental
研究领域[WOS]: Research & Experimental Medicine
关键词[WOS]: INTEGRIN ALPHA(V)BETA(3) EXPRESSION ; GLIOMA INTEGRIN-ALPHA(V)BETA(3) EXPRESSION ; DRUG DEVELOPMENT ; BIODISTRIBUTION CHARACTERISTICS ; PEG(4) LINKERS ; BREAST-CANCER ; ANGIOGENESIS ; DIMER ; MICROPET ; PHARMACOKINETICS
英文摘要:

Purpose: The purpose of this study was to demonstrate the valence of cyclic RGD peptides, P-RGD (PEG(4)-c(RGDfK): PEG(4) = 15-amino-4,710,13-tetraoxapentadecanoic acid), P-RGD(2) (PEG(4)-E[c(RGDfK)](2), 2P-RGD(4) (E{PEG(4)-E[c(RGDfK)](2)}(2), 2P(4)G-RGD(4) (E{PEG(4)-E[G(3)-c(RGDfK)](2)}(2): G(3) = Gly-Gly-Gly) and 6P-RGD(4) (E{PEG(4)-E[PEG(4)-c(RGDfK)](2)}(2)) in binding to integrin alpha(v)beta(3), and to assess the impact of peptide and linker multiplicity on biodistribution properties, excretion kinetics and metabolic stability of their corresponding In-111 radiotracers.

Methods: Five new RGD peptide conjugates (DOTA-P-RGD (DOTA = 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetracetic acid), DOTA-P-RGD(2), DOTA-2P-RGD(4), DOTA-2P4G-RGD(4), DOTA-6P-RGD(4)), and their In-111 complexes were prepared. The integrin alpha(v)beta(3) binding affinity of cyclic RGD conjugates were determined by a competitive displacement assay against I-125-c(RGDyK) bound to U87MG human glioma cells. Biodistribution, planar imaging and metabolism studies were performed in athymic nude mice bearing U87MG human glioma xenografts.

Results: The integrin alpha(v)beta(3) binding affinity of RGD conjugates follows the order of: DOTA-6P-RGD(4) (IC50 = 0.3 +/- 0.1 nM) similar to DOTA-2P4G-RGD(4) (IC50 = 0.2 +/- 0.1 nM) similar to DOTA-2P-RGD(4) (IC50 = 0.5 +/- 0.1 nM) > DOTA-3P-RGD(2) (DOTA-PEG(4)-E[PEG(4)-c(RGDfK)](2): IC50 = 1.5 +/- 0.2 nM) > DOTA-P-RGD(2) (IC50 = 5.0 +/- 1.0 nM) >> DOTA-P-RGD (IC50 = 44.3 +/- 3.5 nM) similar to c(RGDfK) (IC50 = 49.9 +/- 5.5 nM) >> DOTA-6P-RGK(4) (IC50 = 437 +/- 35 nM). The fact that DOTA-6P-RGK(4) had much lower integrin alpha(v)beta(3) binding affinity than DOTA-6P-RGD(4) suggests that the binding of DOTA-6P-RGD(4) to integrin alpha(v)beta(3) is RGD-specific. This conclusion is consistent with the lower tumor uptake for In-111(DOTA-6P-RGK(4)) than that for In-111(DOTA-6P-RGD(4)). It was also found that the G(3) and PEG(4) linkers between RGD motifs have a significant impact on the integrin alpha(v)beta(3)-targeting capability, biodistribution characteristics, excretion kinetics and metabolic stability of In-111-labeled cyclic RGD peptides.

Conclusion: On the basis of their integrin alpha(v)beta(3) binding affinity and tumor uptake of their corresponding In-111 radiotracers, it was conclude that 2P-RGD(4), 2P4G-RGD(4) and 6P-RGD(4) are most likely bivalent in binding to integrin alpha(v)beta(3), and extra RGD motifs might contribute to the long tumor retention times of In-111(DOTA-2P-RGD(4)), In-111(DOTA-2P4G-RGD(4)) and In-111(DOTA-6P-RGD(4)) than that of In-111(DOTA-3P-RGD3) at 72 h p.i. Among the In-111-labeled cyclic RGD tetramers evaluated in the glioma model, In-111(DOTA-2P4G-RGD(4)) has very high tumor uptake with the best tumor/kidney and tumor/liver ratios, suggesting that Y-90(DOTA-2P4G-RGD(4)) and Lu-177(DOTA-2P4G-RGD(4)) might have the potential for targeted radiotherapy of integrin alpha(v)beta(3)-positive tumors.

语种: 英语
所属项目编号: R01 CA115883
项目资助者: Purdue University ; National Cancer Institute (NCI)
WOS记录号: WOS:000299121000027
Citation statistics:
内容类型: 期刊论文
URI标识: http://ir.bjmu.edu.cn/handle/400002259/64262
Appears in Collections:北京大学医药卫生分析中心_期刊论文

Files in This Item:

There are no files associated with this item.


作者单位: 1.Purdue Univ, Sch Hlth Sci, W Lafayette, IN 47907 USA
2.Peking Univ, Med Isotopes Res Ctr, Beijing 100083, Peoples R China

Recommended Citation:
Shi, Jiyun,Zhou, Yang,Chakraborty, Sudipta,et al. Evaluation of In-111-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability[J]. THERANOSTICS,2011,1:322-340.
Service
Recommend this item
Sava as my favorate item
Show this item's statistics
Export Endnote File
Google Scholar
Similar articles in Google Scholar
[Shi, Jiyun]'s Articles
[Zhou, Yang]'s Articles
[Chakraborty, Sudipta]'s Articles
CSDL cross search
Similar articles in CSDL Cross Search
[Shi, Jiyun]‘s Articles
[Zhou, Yang]‘s Articles
[Chakraborty, Sudipta]‘s Articles
Related Copyright Policies
Null
Social Bookmarking
Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit

Items in IR are protected by copyright, with all rights reserved, unless otherwise indicated.

 

 

Valid XHTML 1.0!
Copyright © 2007-2017  北京大学医学部 - Feedback
Powered by CSpace